Academic research: Review of children & adolescent gender identity services
Get tender notifications and more sign up now and never miss an opportunity again. Already a member? log in to your account.
Title | Academic research: Review of children & adolescent gender identity services |
FTS UK (Find A Tender Serive) | FTS/032508-2023 |
Type | Contract awards |
Date Published | 2023-11-02 |
Deadline | |
Nature Of Contract | Service contract |
Awarding Authority | NHS England |
Procedure | Not Specified |
Description : |
Section I: Contracting authority/entity I.1) Name and addresses NHS England Quarry House, Quarry Hill Leeds LS2 7UE Contact: Commercial Contract Management Team Email: england.commercialqueries@nhs.net Country: United Kingdom NUTS code UK - United Kingdom Internet address(es) Main address: https://www.england.nhs.uk/ Buyer's address: https://www.england.nhs.uk/ Section II: Object II.1) Scope of the procurement II.1.1) Title: Academic research: Review of children & adolescent gender identity services II.1.2) Main CPV code 85100000 - Health services II.1.3) Type of contract: Services II.2) Description II.2.3) Place of performance NUTS codes UK - United Kingdom II.2.4) Description of the procurement at the time of conclusion of the contract: NHS England and Improvement recently announced an independent review into children and adolescent gender identity development services (for under 17s) which is commissioned by NHS Englands specialised commissioning directorate - (ToR of review - https://www.england.nhs.uk/wp-content/uploads/2020/09/GIDS_independent_review_ToR.pdf. This review requires extensive, expert led research and engagement in order to successfully make recommendations to inform the future shape of gender identity development services for children and young people. A key principle of the review is that it must be participative, evidence based and incorporate lived experience in order to formulate conclusions and recommendations that will command the confidence of stakeholders. The research streams outlined in this specification have been designed to achieve these ends. Specifically, the outputs required are to achieve the best available collation of published evidence, and qualitative and quantitative research that can feasibly be produced within the timeframe of the review. Recognising that the published evidence is unlikely to be of high enough quality to form the sole basis for the recommendations of the review, a process is needed for synthesising the published evidence and research outputs of the academic team(s) with stakeholder submissions and expert opinion. This will involve a consensus development approach, using Delphi or other appropriate tools, and we would anticipate that the research team(s) would be integral to this important stage of the review. The review will report to NHS Englands Commissioning Committee and a project assurance group, Chaired by Dr Cass has been set up to oversee the work. The project assurance group will assist the Chair in ensuring the process and conduct of review is appropriate, fit for purpose and that decisions are transparent. The assurance group does not contain subject matter experts or service users and their role is strictly the governance of the review process, not to inform outcome. The group includes ethics, legal, and research expertise, plus experience in CYP advocacy, and CYP participation. II.2.7) Duration of the contract, framework agreement, dynamic purchasing system or concession Start date: 8 September 2021 End date: 8 January 2024 II.2.13) Information about European Union Funds The procurement is related to a project and/or programme financed by European Union funds: No Section IV. Procedure IV.2) Administrative information IV.2.1) Contract award notice concerning this contract Notice number: 2021/S 000-008342 Section V. Award of contract/concession Contract No: 1 Title: Academic research: Review of children & adolescent gender identity services V.2) Award of contract/concession V.2.1) Date of conclusion of the contract/concession award decision: 8 September 2021 V.2.2) Information about tenders The contract/concession has been awarded to a group of economic operators: No V.2.3) Name and address of the contractor/concessionaire University of York Heslington, York York YO10 5DD Country: United Kingdom NUTS code UK - United Kingdom National registration number RC000679 Internet address http://www.york.ac.uk The contractor/concessionaire is an SME No V.2.4) Information on value of the contract/lot/concession (at the time of conclusion of the contract;excluding VAT) Total value of the procurement: 897,512 Section VI. Complementary information VI.4) Procedures for review VI.4.1) Review body The High Court The Strand London WC2A 2LL Country: United Kingdom Internet address https://www.judiciary.uk/courts-and-tribunals/high-court/ VI.4.2) Body responsible for mediation procedures NHS England 1st Floor, Quarry House, Quarry Hill Leeds LS2 7UE Country: United Kingdom Internet address https://www.england.nhs.uk// Section VII: Modifications to the contract/concession VII.1) Description of the procurement after the modifications VII.1.1) Main CPV code 85100000 - Health services VII.1.3) Place of performance NUTS code UK - United Kingdom VII.1.4) Description of the procurement: NHS England and Improvement recently announced an independent review into children and adolescent gender identity development services (for under 17s) which is commissioned by NHS Englands specialised commissioning directorate - (ToR of review - https://www.england.nhs.uk/wp-content/uploads/2020/09/GIDS_independent_review_ToR.pdf. This review requires extensive, expert led research and engagement in order to successfully make recommendations to inform the future shape of gender identity development services for children and young people. A key principle of the review is that it must be participative, evidence based and incorporate lived experience in order to formulate conclusions and recommendations that will command the confidence of stakeholders. The research streams outlined in this specification have been designed to achieve these ends. Specifically, the outputs required are to achieve the best available collation of published evidence, and qualitative and quantitative research that can feasibly be produced within the timeframe of the review. Recognising that the published evidence is unlikely to be of high enough quality to form the sole basis for the recommendations of the review, a process is needed for synthesising the published evidence and research outputs of the academic team(s) with stakeholder submissions and expert opinion. This will involve a consensus development approach, using Delphi or other appropriate tools, and we would anticipate that the research team(s) would be integral to this important stage of the review. The review will report to NHS Englands Commissioning Committee and a project assurance group, Chaired by Dr Cass has been set up to oversee the work. The project assurance group will assist the Chair in ensuring the process and conduct of review is appropriate, fit for purpose and that decisions are transparent. The assurance group does not contain subject matter experts or service users and their role is strictly the governance of the review process, not to inform outcome. The group includes ethics, legal, and research expertise, plus experience in CYP advocacy, and CYP participation. VII.1.5) Duration of the contract, framework agreement, dynamic purchasing system or concession Start date: 8 September 2021 End date: 8 January 2024 VII.1.6) Information on value of the contract/lot/concession (excluding VAT) Total value of the contract/lot/concession: 1,227,114 VII.1.7) Name and address of the contractor/concessionaire University of York Heslington, York York YO10 5DD Country: United Kingdom NUTS code UK - United Kingdom National registration number RC000679 Internet address http://www.york.ac.uk The contractor/concessionaire is an SME No VII.2) Information about modifications VII.2.1) Description of the modifications Nature and extent of the modifications (with indication of possible earlier changes to the contract): Contract variation of value: 329,602 Zero-cost contract extensions from the original contract end date to 08/01/2024 VII.2.2) Reasons for modification Need for modification brought about by circumstances which a diligent contracting authority/entity could not foresee. Description of the circumstances which rendered the modification necessary and explanation of the unforeseen nature of these circumstances: Both the contract variation of 329,602 and contract extensions were due to the Statutory Instrument necessary to undertake part of the work. VII.2.3) Increase in price Updated total contract value before the modifications (taking into account possible earlier contract modifications, price adaptions and average inflation) Value excluding VAT: 897,512 Total contract value after the modifications Value excluding VAT: 1,227,114 |
CPV Codes |
85100000 |
Sign-up now to receive weekly OJEU reports for the UK, your sector and/or elsewhere in the EU. We also report on the procurement of EC Institutions. |
|